Oncology & Cancer
Gene expression predicts chemotherapy sensitivity of triple-negative breast cancer
German researchers have identified an unexpected molecular marker that predicts how sensitive hard-to-treat triple-negative breast cancers are to chemotherapy.
May 5, 2011
0
0